Skip to content
Monday, March 27, 2023
Latest:
  • KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
  • The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
  • AlumiFuel Reduces the Authorized Number of Shares
  • Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
  • FACT, Inc. Announces Patricia Trompeter as CEO
Biotech Research Report

Biotech Research Report

Know First, Act First

  • Covid-19
  • General
  • Cannabis
  • Fiscal & Financing
  • Pharmaceutical
  • Trending

BIOTCHNO

BIOTCHNO Fiscal & Financing 

Regor Therapeutics Announces Completion of $90 Million Series B Financing

February 18, 2021April 8, 2021 Bachittar

Regor Therapeutics Announces Completion of $90 Million Series B Financing Canada NewsWire SHANGHAI , Feb. 18, 2021 /CNW/ — Regor

Read more
BIOTCHNO Fiscal & Financing 

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2020

February 18, 2021April 15, 2021 Bachittar

  Canada NewsWire KELOWNA, BC,Feb. 18, 2021/CNW/ –The Valens Company Inc.(TSX: VLNS) (OTCQX: VLNCF) (the“Company,” “The Valens Company” or“Valens”), a leading

Read more
BIOTCHNO Fiscal & Financing 

Seegene posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-won club

February 18, 2021April 15, 2021 Bachittar

Canada NewsWire SEOUL, South Korea,Feb. 18, 2021/CNW/ —South Korea’sleading molecular diagnostics firm Seegene Inc. (KQ096530) reported preliminary financial results for

Read more
BIOTCHNO Trending 

InnerScope Hearing (INND)To Launch New Self-Fitting Direct-to-Consumer Hearing Aids with Remote Programming Feature

February 17, 2021April 15, 2021 Bachittar

InnerScope Hearing (INND)To Launch New Self-Fitting Direct-to-Consumer Hearing Aids with Remote Programming Feature InnerScope to Launch the Latest in Direct-to-Consumer

Read more
BIOTCHNO Covid-19 

CIRION and Providence Therapeutics Collaborate to Support COVID-19 Clinical Research

February 17, 2021April 15, 2021 Bachittar

Canada NewsWire LAVAL, QC,Feb. 17, 2021/CNW/ – CIRION BioPharma Research Inc. (“CIRION”) a leading Contract Research Organization (CRO), and Providence Therapeutics Holdings

Read more
BIOTCHNO Fiscal & Financing 

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

February 16, 2021April 15, 2021 Bachittar

  Canada NewsWire DUBLIN,Feb. 16, 2021/CNW/ — Medtronic plc (NYSE:MDT) announced today that it will report financial results for its third

Read more
BIOTCHNO Featured 

Menarini Silicon Biosystems announces launch of CellMag(TM) product line offering affordable Gold Standard Circulating Tumor Cells capture

February 16, 2021May 24, 2021 Bachittar

CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood

Read more
BIOTCHNO Cannabis 

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

Read more
BIOTCHNO General 

Nex Cubed Partners with Government of Canada to Support Canadian Digital Health Startups

February 11, 2021May 24, 2021 Bachittar

  Canada NewsWire SAN DIEGO,Feb. 11, 2021/CNW/ — Nex Cubed, a leader in early-stage innovation and startup acceleration, has announced

Read more
BIOTCHNO General 

Ultrack Announces Two New Contracts with High-End Car Rental Companies While in Final Phase of Revolutionary ELD Device Prelaunch

February 11, 2021April 15, 2021 Bachittar

Ultrack Announces Two New Contracts with High-End Car Rental Companies While in Final Phase of Revolutionary ELD Device Prelaunch Concord,

Read more
  • ← Previous
  • Next →

Cannabis

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)
BIOTCHNO Cannabis 

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC)

February 15, 2021April 14, 2021 Bachittar

SiliCycle signs a Letter of Intent with the Société Québécoise du Cannabis (SQDC) QUEBEC CITY , Dec. 15, 2020 /CNW

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO Cannabis 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 19, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479